INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단 FILES APPLICATION FOR "MARKER FOR PREDICTING THERAPEUTIC RESPONSE TO IMMUNE CHECKPOINT INHIBITOR IN RENAL CANCER AND METHOD FOR PREDICTING THERAPEUTIC RESPONSE BY USING SAME"

GENEVA, March 10 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566) filed a patent application (PCT/KR2024/013130) for "MARKER FOR PREDICTING THERAPEUTIC RESPONSE TO IMMUNE CHECKPOINT INHIBITOR IN RENAL CANCER, AND METHOD FOR PREDICTING THERAPEUTIC RESPONSE BY USING SAME" on Sep 02, 2024. With publication no. WO/2025/048570, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellect...